Kalkine: Robots and Their Impact on the FTSE 350 Companies

3 min read | June 02, 2025 05:37 PM BST | By Team Kalkine Media

Highlights

  • Citigroup forecasts substantial growth in the robotics market, with millions of humanoid robots in circulation by mid-century.

  • Start-ups like EngineAI and Unitree are showcasing advanced robots, with applications spanning healthcare, policing, and beyond.

  • China is positioning itself to be a major player in the robotics sector, influencing global trends.

The robotics sector is on the brink of substantial growth in the coming decades, driven by technological advances and the rising demand for automation across various industries. Many companies within the FTSE 350 companies, particularly those involved in technology, healthcare, and manufacturing, are increasingly tied to the developments in robotics, which may significantly affect their operations.

Within the robotics industry, advancements are being made in a variety of areas, including humanoid robots capable of performing complex tasks and specialized machines that enhance productivity in industrial settings. The introduction of robotics technology across multiple sectors can create efficiencies and address challenges faced by companies, leading to notable changes in how businesses operate.

China's Role in Robotics

China is emerging as a dominant force in the global robotics market, investing heavily in the development of robotic technology. The country is a leader in producing and consuming robots, with several Chinese companies at the forefront of humanoid robot innovation. As the robotics sector grows, China’s increasing influence could have widespread implications for global trends and competition in the field.

Moreover, China is playing a critical role in the industrial robot sector, where the demand for automation in manufacturing continues to rise. Companies operating within sectors such as manufacturing and logistics may face both opportunities and challenges as Chinese advancements in robotics drive further competition.

Start-ups and Technological Innovations

Innovative start-ups such as EngineAI and Unitree are pushing the boundaries of robotics by developing robots for various applications. EngineAI focuses on creating AI-powered robots capable of learning and adapting to new tasks, while Unitree specializes in versatile robots that can serve in diverse settings, from robot marathons to more intense environments like combat training.

These emerging companies demonstrate how the robotics field is diversifying, with new applications for robots in industries ranging from healthcare to public safety. The technological innovations being showcased could lead to improvements in operational efficiency, safety, and labor shortage mitigation in several key sectors.

Applications in Key Industries

The adoption of robots is expanding in multiple industries. In healthcare, robotics systems are increasingly used for surgeries, patient care, and administrative tasks, transforming the efficiency and quality of service. Similarly, law enforcement agencies are exploring robots for roles such as surveillance, assisting in dangerous situations, and apprehending suspects, which can enhance officer safety.

The defense sector is also seeing a growing use of robots, designed to take on high-risk missions, reducing the exposure of soldiers to danger. These innovations in robotics are reshaping the operations of industries like defense, healthcare, and law enforcement, making them safer and more efficient. As robotics technology continues to evolve, it is likely to have an even greater impact on industries worldwide, including those represented by companies in the FTSE 350.

The growing presence of robotics across various sectors highlights an ongoing transformation of industries, with companies in the FTSE 350 increasingly adopting automation to enhance their operations. As the robotics field continues to progress, its influence on global markets and industries is expected to expand significantly.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next